The Penn group also tested CTL019 in myeloma after autologous transplant and reported one individual who obtained a CR that persisted for 12 months
The Penn group also tested CTL019 in myeloma after autologous transplant and reported one individual who obtained a CR that persisted for 12 months. (Garfallet al2015) Of note, this response was obtained despite CD19 not being expressed around the majority (99. 95%) from the patients neoplastic plasma cells. To avoid W cell aplasia, Ramos et…